Učitavanje...
Panitumumab in Metastatic Colorectal Cancer: The Importance of Tumour RAS Status
Tumour biomarker status is being used more and more frequently to guide treatment decisions in patients with metastatic colorectal cancer (mCRC). Continued cycles of hypothesis generation and biomarker testing in retrospective, prospective–retrospective and prospective analyses from studies of the e...
Spremljeno u:
| Izdano u: | Drugs |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer International Publishing
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4419154/ https://ncbi.nlm.nih.gov/pubmed/25895463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-015-0386-x |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|